Terms: = Testicular cancer AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2 AND Treatment
11 results:
1. Expression and roles of system L amino acid transporters in human embryonal carcinoma cells.
Chatsirisupachai K; Kitdumrongthum S; Panvongsa W; Janpipatkul K; Worakitchanon W; Lertjintanakit S; Wongtrakoongate P; Chairoungdua A
Andrology; 2020 Nov; 8(6):1844-1858. PubMed ID: 32741077
[TBL] [Abstract] [Full Text] [Related]
2. Recent malignant testicular tumor trend in Japan, a country with an aging population: a large-scale study of 2012-2015 hospital-based cancer registry data.
Kojo K; Kawai K; Kawahara T; Kimura T; Kandori S; Nagumo Y; Nitta S; Kojima T; Okuyama A; Higashi T; Nishiyama H
Jpn J Clin Oncol; 2020 Sep; 50(10):1201-1208. PubMed ID: 32627833
[TBL] [Abstract] [Full Text] [Related]
3. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
[TBL] [Abstract] [Full Text] [Related]
4. [The clinical characteristics and outcomes of 16 Burkitt' s lymphoma with testicular involvement].
Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Zhang YH
Zhonghua Xue Ye Xue Za Zhi; 2016 Sep; 37(9):768-773. PubMed ID: 27719719
[TBL] [Abstract] [Full Text] [Related]
5. Stage I testicular seminoma: management and controversies.
Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
Crit Rev Oncol Hematol; 2009 Jul; 71(1):22-8. PubMed ID: 19046898
[TBL] [Abstract] [Full Text] [Related]
6. Recent advances in management of patients with platinum-refractory testicular germ cell tumors.
Kollmannsberger C; Nichols C; Bokemeyer C
Cancer; 2006 Mar; 106(6):1217-26. PubMed ID: 16463389
[TBL] [Abstract] [Full Text] [Related]
7. treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy.
Kollmannsberger C; Mayer F; Kuczyk M; Kanz L; Bokemeyer C
World J Urol; 2001 Apr; 19(2):120-5. PubMed ID: 11374314
[TBL] [Abstract] [Full Text] [Related]
8. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
Bokemeyer C
Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
[TBL] [Abstract] [Full Text] [Related]
9. Pre-clinical activity of taxol in non-seminomatous germ cell tumor cell lines and nude mouse xenografts.
Dunn TA; Grünwald V; Bokemeyer C; Casper J
Invest New Drugs; 1997; 15(2):91-8. PubMed ID: 9220287
[TBL] [Abstract] [Full Text] [Related]
10. Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer.
Studer UE; Fey MF; Calderoni A; Kraft R; Mazzucchelli L; Sonntag RW
Eur Urol; 1993; 23(4):444-9. PubMed ID: 7687549
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostics and therapy of germinal testicular tumors.
Vahlensieck W; Jaeger N
Urol Int; 1985; 40(1):48-59. PubMed ID: 2983472
[TBL] [Abstract] [Full Text] [Related]
